News

Investors in Air Lease Corporation AL need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 21, 2025 $30.00 Put had some of the highest

Carnival Corporation & plc (CCL) has been riding a wave of record demand across the cruise industry and its latest quarter underscores that momentum. The company delivered its eighth straight

Amid the looming tariff uncertainty, persistent inflation concerns and weakening consumer confidence, U.S. retailers face increased volatility.

According to an article on Yahoo Finance, the recent

Hewlett Packard Enterprise’s HPE server business grew 5.6% in the second quarter of fiscal 2025. It expects its third-quarter revenues to rise in mid-teens sequentially and fiscal 2025 server

Shares of Host Hotels & Resorts Inc. HST have gained 9.8% in the past three months compared with the industry’s rise of 1.7%.

With a solid portfolio of upscale hotels across lucrative markets, Host

For investors seeking momentum, SPDR Gold Shares GLD is probably on the radar. The fund just hit a 52-week high and is up 39.19% from its 52-week low price of $228.52/share.

But are there more gains

Altria Group, Inc. (MO) is sharpening focus on the booming nicotine pouch category and its on! brand is leading the charge. In the second quarter of 2025, shipments rose 26.5% year over year to 52.1

Tesla, Inc. TSLA has cut the price of its Model 3 rear-wheel drive in China as competition from domestic automakers intensifies. Deliveries of this version are expected to start this month. The new

TJX Companies’ TJX international business remains a key growth driver, underscoring the strength of its off-price retail model beyond the United States. In the second quarter of fiscal 2026, TJX

Nokia NOK has announced a contract with Extreme Broadband ("EBB") and its subsidiary, Open DC, to enhance the performance and security of Open DC’s Artificial Intelligence (AI) data centers across

NIO Inc. NIO reported a loss per American Depositary Share (ADS) of 32 cents in the second quarter of 2025, wider than the Zacks Consensus Estimate of a loss of 30 cents. The company had incurred a

Investors in Alcon Inc. ALC need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 20, 2026 $70.00 Call had some of the highest implied

UnitedHealth Group Incorporated UNH is again under scrutiny after questions were raised about how it handled loans to healthcare providers in the wake of the 2024 Change Healthcare cyberattack. UNH

CrowdStrike CRWD is seeing strong momentum in its Next Generation (Next-Gen) Security Information and Event Management (SIEM) as part of its mission to protect enterprises against evolving cyber

Guidewire Software, Inc. GWRE is slated to report fourth-quarter fiscal 2025 results on Sept. 4. Management expects revenues to be between $332 million and $340 million. The Zacks Consensus Estimate

Hilltop Holdings Inc. HTH shares touched a new 52-week high of $35.63 during Friday’s trading session. Over the past month, the stock has risen 15.6%, outperforming the industry, the Zacks Finance

Shares of Viking Therapeutics VKTX have lost over 20% in the past month, significantly underperforming the industry’s 1% growth. The stock has also underperformed the sector and the S&P 500 during

Bread Financial Holdings, Inc. BFH closed at $66.19 on Friday, near its 52-week high of $67.33. This proximity underscores investor confidence. It has the ingredients for further price

Pembina Pipeline Corporation PBA is a prominent midstream energy company operating across North America. Its main business revolves around moving, storing and processing oil, natural gas and natural

Palo Alto Networks PANW and CrowdStrike CRWD are both at the forefront of the cybersecurity space, playing key roles in guarding organizations from extensive cyberattacks. While Palo Alto Networks

Considering we have no major economic or Q2 earnings reports out ahead of today’s holiday-shortened week, it has the capacity to be quite impactful to the stock market. That’s because this is also

CorMedix’s CRMD lead drug, DefenCath (Taurolidine + Heparin), is currently its only marketed product that generates revenues for the company.

The FDA approved CorMedix’s DefenCath in late 2023 as